JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsukashita, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tsukashita, M.
Related Collections
Right arrow Cardiac - pharmacology

J Thorac Cardiovasc Surg 2009;137:257-258
© 2009 The American Association for Thoracic Surgery

Letter to the Editor

Reply to the Editor:

Masaki Tsukashita

Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

The first 20% of the full text of this article appears below.

We appreciate the interest that Ramaraj has shown in our article, and we are deeply honored by his comments.1Go He possesses expertise in a broad area of medical science, not only in ischemic cardiomyopathy, the subject for our study.

As Ramaraj points out, hyperkalemia induced . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.